CSIMarket Company Name, Ticker, Competitors, else..
 
Beta Bionics Inc   (NASDAQ: BBNX)
 
Price: $19.5450 $-0.41 -2.030%
Day's High: $20.229999542236328 Week Perf: 1.06 %
Day's Low: $ 19.48 30 Day Perf: 46.4 %
Volume (M): 109,676 52 Wk High: $ 32.71
Volume (M$): $ 0 52 Wk Avg: $18.13
Open: $19.75 52 Wk Low: $8.80



 Market Capitalization (Millions $) 871
 Shares Outstanding (Millions) 45
 Employees 420
 Revenues (TTM) (Millions $) 120
 Net Income (TTM) (Millions $) -73
 Cash Flow (TTM) (Millions $) -5
 Capital Exp. (TTM) (Millions $) 5

Business Description


The document is an excerpt from an Annual Report on Form 10-K, detailing the company's business operations, risk factors, properties, legal proceedings, market information, management's discussion and analysis, financial statements, corporate governance, executive compensation, and other regulatory disclosures. It includes forward-looking statements regarding the company's future operations, financial condition, and business strategy, along with associated risks and uncertainties.


   Company Address: 11 Hughes Irvine 92618 CA
   Company Phone Number: 427-7785   Stock Exchange / Ticker: NASDAQ BBNX


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
• View Complete Report
   



Stock Market Announcement

Beta Bionics Closes at $2346 Million in Initial Public Offering: A Milestone for Advanced Diabetes Management Solutions

Published Fri, Jan 31 2025 10:57 PM UTC

Beta Bionics Closes at $234.6 Million in Initial Public Offering: A Milestone for Advanced Diabetes Management SolutionsIrvine, California - January 31, 2025 - In a significant stride for the medical technology sector, Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering force in advanced diabetes management solutions, has successfully closed its upsized initial public offering (...
Management Announcement

Beta Bionics Takes Bold Step with $204 Million IPO, Paving the Way for Diabetes Innovation,

Published Thu, Jan 30 2025 3:35 AM UTC

Beta Bionics Aims for Growth with $204 Million IPO: A New Era in Diabetes ManagementIn a bold move signaling its ambitions for expansion, Beta Bionics, Inc. headquartered in Irvine, California, has announced the pricing of its initial public offering (IPO), raising $204 million in the process. The leading innovator in advanced diabetes management solutions has set the price ...



Fundamental Analysis

Valuation Current
Price to Earnings PE Ratio (TTM) -
Price to Earnings PE Ratio (Expected) -
Price to Sales (TTM) 7.28
Price to Sales (Expected) -
Price to Book 3.4
PEG (TTM) -

Financial Strength Current
Quick Ratio 1.7
Working Capital Ratio 3.63
Leverage Ratio (MRQ) 0.14
Total Debt to Equity -
Interest Coverage (TTM) -
Debt Coverage (TTM) -

Per Share Current
Earnings (TTM) -1.68 $
Revenues (TTM) 2.68 $
Cash Flow (TTM) -
Cash 0.99 $
Book Value 5.76 $
Dividend (TTM) 0 $

Efficiency Current
Revenue per Employee (TTM) 284,555
Net Income per Employee (TTM) -173,745
Receivable Turnover Ratio (TTM) 7.65
Inventory Turnover Ratio (TTM) 2.23
Asset Turnover Ratio (TTM) 0.38

Profitability Ratios Current
Gross Margin (MRQ) 59.04 %
Operating Margin (MRQ) -79.9 %
Net Margin (MRQ) -73.1 %
Net Cash Flow Margin (MRQ) 0 %
Effective Tax Rate (TTM) -

Management Effectiveness Current
Return On Assets (TTM) -
Return On Investment (TTM) -
Return On Equity (TTM) -
Dividend Yield -
Pay out Ratio (TTM) -



Beta Bionics Inc's Segments
I Let    2.14 % of total Revenue
Single Use Products    67.53 % of total Revenue





Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.